Actualités

Rapport de l’EMCDDA sur le protoxyde d’azote 

Pour compléter les éléments d’actualité concernant les problématiques d’usage du protoxyde d’azote, vous trouverez les données récentes, à l’échelle européenne, publiées par l’Observatoire Européen des Drogues et des Toxicomanies (l’EMCDDA), en décembre 2022. Recreational use of nitrous oxide — a growing concern for Europe. Leon Van Aerts, Joanna de Morais (1), Michael Evans-Brown (1), Rita …

Rapport de l’EMCDDA sur le protoxyde d’azote  Lire la suite »

Chemsex in HIV pre-exposure prophylaxis users: Assessment of mood disorders and addictive behavior.

Peyriere H, Jacquet JM, Peries M, Tribout V, Broche B, Mauboussin JM, Makinson A, Perrollaz C, Ferreyra M, Rouanet I, Montoya-Ferrer A, El-Majjaoui S, Corriol-Bonifas F, Fraisse T, Grau F, Laureillard D, Nagot N, Reynes J, Donnadieu-Rigole H. Chemsex in HIV pre-exposure prophylaxis users: Assessment of mood disorders and addictive behavior. Fundam Clin Pharmacol. 2022 Nov 20. …

Chemsex in HIV pre-exposure prophylaxis users: Assessment of mood disorders and addictive behavior. Lire la suite »

Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey

Blayac L, Ponte C, Lavaud M, Micallef J, Lapeyre-Mestre M. Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey. Therapie. 2022 Oct 8:S0040-5957(22)00171-8. doi: 10.1016/j.therap.2022.10.003. Epub ahead of print. PMID: 36283856.

Adverse events of recreational cannabis use during pregnancy reported to the French Addictovigilance Network between 2011 and 2020.

Bouquet E, Eiden C, Fauconneau B, Pion C; French Addictovigilance Network (FAN), Pain S, Pérault-Pochat MC. Adverse events of recreational cannabis use during pregnancy reported to the French Addictovigilance Network between 2011 and 2020. Sci Rep. 2022 Oct 3;12(1):16509. doi: 10.1038/s41598-022-19197-2. PMID: 36192621.

Cross-sectional study of the prevalence of prescription opioids misuse in French patients with chronic non-cancer pain: An update with the French version of the POMI scale.

Kerckhove N, Delage N, Bertin C, Kuhn E, Cantagrel N, Vigneau C, Delorme J, Lambert C, Pereira B, Chenaf C, Authier N; Poma Network. Cross-sectional study of the prevalence of prescription opioids misuse in French patients with chronic non-cancer pain: An update with the French version of the POMI scale. Front Pharmacol. 2022 Sep 5;13:947006. doi: …

Cross-sectional study of the prevalence of prescription opioids misuse in French patients with chronic non-cancer pain: An update with the French version of the POMI scale. Lire la suite »

What is the potential for abuse of lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion

Carton L, Icick R, Weibel S, Dematteis M, Kammerer E, Batisse A, Rolland B. What is the potential for abuse of lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion. Expert Rev Clin Pharmacol. 2022 Aug 18:1-5. doi: 10.1080/17512433.2022.2112950. Epub ahead of print. PMID: 35959655.

Retour en haut